Osteoporosis is a common metabolic disease in middle-aged and elderly people. It is
characterized by a reduction in bone mass, compromised bone microstructure, heightened …

Osteoporosis is a systemic skeletal disease characterized by decreased bone mass,
destruction of bone microstructure, raised bone fragility, and enhanced risk of fractures. The …

Metabolic diseases can change the gut microbiota composition and function, and
pathogenic bacteria contribute to the development of metabolic disorders. Polyphenols may …

Osteoporosis (OP) is a systemic disease characterized by decreased bone mass and
degeneration of bone microstructure. In recent years, more and more researches have …

Osteoporosis is a systemic skeletal disease that seriously endangers the health of middle-
aged and older adults. Recently, with the continuous deepening of research, an increasing …

Osteoporosis and osteoarthritis are common diseases in an aging society, are considered
metabolic diseases, and affect the quality of life of older adults. In addition, the gut …

Osteoporosis is the prevalent metabolic bone disease characterized by a decrease in bone
quantity and/or quality and an increase in skeletal fragility, which increases susceptibility to …

Postmenopausal osteoporosis (PMO) results from a reduction in bone mass and
microarchitectural deterioration in bone tissue due to estrogen deficiency, which may …

Osteoporosis (OP) is a skeletal disorder characterized by decreased bone density,
alterations in bone microstructure, and increased damage to the bones. As the population …

Osteoporosis is a disease characterized by low bone mass and alterations of bone
microarchitecture, with an increased risk of fractures. It is a multifactorial disorder that is …